The Clarity IBD podcast has recently been published, listen to the podcast here.
In this episode, Professor Tariq Iqbal talks to PDr Tariq Ahmad about how this pragmatic trial adopted an agile approach to rapidly answer a key question: Do common immunosuppressants used to treat Inflammatory Bowel Disease (IBD) reduce the effectiveness of COVID-19 vaccines?
They also explain how this study, which involved almost 7,000 participants from 92 UK hospitals, was set up and recruited to at an unprecedented speed.
Login to your BSG member account to read and post comments on this page